Scarica l'app Stockscreener
13.00
0.00%
0.00
Precedente Chiudi:
$13.00
Aprire:
$13.51
Volume 24 ore:
3,573
Relative Volume:
0.71
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-10.22%
1M Prestazione:
-5.80%
6M Prestazione:
+6.12%
1 anno Prestazione:
+87.05%
Intervallo 1D:
$13.00
$14.00
Intervallo di 1 settimana:
$12.69
$14.50
Portata 52W:
$5.45
$16.75
Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile
Nome
Newamsterdam Pharma Company N V
Settore
Industria
Telefono
31 35 206 2971
Indirizzo
Gooimeer 2-35, Naarden
Confronta NAMSW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAMSW
Newamsterdam Pharma Company N V
|
13.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.12 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.05 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.69 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.66 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
339.72 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie
Topper James N, NewAmsterdam Pharma director, buys $15,638 in shares - Investing.com
Topper James N, NewAmsterdam Pharma director, buys $15,638 in shares By Investing.com - Investing.com UK
Recap Report: Will NewAmsterdam Pharma Company NV Equity Warrant stock hit new highs in YEARTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Newamsterdam pharma CFO sells shares worth $1.5 million - MSN
Revenue Check: Is EBAYL stock showing strong momentumJuly 2025 Summary & Risk Managed Trade Strategies - خودرو بانک
Published on: 2025-09-17 06:53:21 - خودرو بانک
Setup Watch: Should value investors consider NewAmsterdam Pharma Company N.V. Equity Warrant2025 Performance Recap & Growth Oriented Trade Recommendations - خودرو بانک
Published on: 2025-09-16 23:28:12 - خودرو بانک
Aug Highlights: Will NewAmsterdam Pharma Company NV outperform the market in YEARJuly 2025 Macro Moves & Weekly Return Optimization Plans - خودرو بانک
Stock Analysis: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political risk2025 Big Picture & Detailed Earnings Play Strategies - خودرو بانک
Retail Trends: Will NewAmsterdam Pharma Company N.V. Equity Warrant stock hit new highs in YEAR2025 Market WrapUp & Weekly Watchlist for Hot Stocks - خودرو بانک
Resistance Check: Will NewAmsterdam Pharma Company NV benefit from sector rotation2025 Growth vs Value & Risk Adjusted Buy and Sell Alerts - خودرو بانک
PTM Wealth Management LLC Takes $256,000 Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V. $NAMS Stock Position Reduced by Fred Alger Management LLC - MarketBeat
Market Fear: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trendsWeekly Market Summary & Fast Entry Momentum Trade Alerts - خودرو بانک
Tech Rally: Is Formula One Group stock showing strong momentumEntry Point & Expert Curated Trade Ideas - خودرو بانک
New Highs: What is Comcast Corporation’s valuation compared to sectorWeekly Trade Recap & Community Driven Trade Alerts - خودرو بانک
Revenues Not Telling The Story For NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - 富途牛牛
Signal Recap: Can NewAmsterdam Pharma Company N.V. Equity Warrant sustain earnings growthJuly 2025 Rallies & Smart Allocation Stock Reports - خودرو بانک
Louise Frederika Kooij Sells 150,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - MarketBeat
Woodline Partners LP Has $50 Million Stake in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month HighTime to Buy? - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume on Insider Buying Activity - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 9.7% on Insider Selling - MarketBeat
Insider Buying: NewAmsterdam Pharma (NASDAQ:NAMS) Director Purchases 1,260 Shares of Stock - MarketBeat
Is it time to cut losses on NewAmsterdam Pharma Company N.V. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - Newser
Risk vs reward if holding onto NewAmsterdam Pharma Company N.V. Equity WarrantRecession Risk & Safe Entry Trade Signal Reports - Newser
Alliancebernstein L.P. Acquires 383,888 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
What’s next for NewAmsterdam Pharma Company N.V. Equity Warrant stock price2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. Equity Warrant stockTrade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
When is the best time to exit NewAmsterdam Pharma Company N.V. Equity Warrant2025 Price Action Summary & High Return Trade Guides - Newser
Market reaction to NewAmsterdam Pharma Company N.V. Equity Warrant’s recent newsJuly 2025 Decliners & Reliable Momentum Entry Alerts - Newser
NewAmsterdam Pharma Company N.V. stock outlook for YEAR2025 Analyst Calls & Capital Protection Trading Alerts - Newser
Leading vs lagging indicators on NewAmsterdam Pharma Company N.V. performanceEntry Point & Stepwise Trade Signal Implementation - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
Technical signs of recovery in NewAmsterdam Pharma Company N.V. Equity Warrant2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
Analyzing drawdowns of NewAmsterdam Pharma Company N.V. with statistical toolsEarnings Miss & Expert Verified Movement Alerts - Newser
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD By Investing.com - Investing.com Nigeria
Parkman Healthcare Partners LLC Purchases 24,839 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V.’s volatility index tracking explainedWeekly Stock Summary & Capital Efficient Trading Techniques - Newser
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V.July 2025 Big Picture & Growth Focused Stock Reports - Newser
what to expect from newamsterdam pharma company n.v. equity warrant in the next 30 days2025 Big Picture & Capital Efficiency Focused Ideas - Newser
What to expect from NewAmsterdam Pharma Company N.V. Equity Warrant in the next 30 daysSwing Trade & Smart Investment Allocation Tips - Newser
Trexquant Investment LP Invests $1.35 Million in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD - Investing.com
Newamsterdam Pharma CAO Kooij sells $3.8m in shares By Investing.com - Investing.com Australia
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com South Africa
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares - Investing.com India
Newamsterdam Pharma CAO Kooij sells $3.8m in shares - Investing.com
NewAmsterdam Pharma Company N.V. $NAMS Stock Holdings Lowered by Cutter Capital Management LP - MarketBeat
Newamsterdam Pharma Company N V Azioni (NAMSW) Dati Finanziari
Non sono disponibili dati finanziari per Newamsterdam Pharma Company N V (NAMSW). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.67%
0.47%
Capitalizzazione:
|
Volume (24 ore):